Orbimed Advisors - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 93 filers reported holding SURFACE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q4 2021$2,237,000
-67.5%
467,945
-48.6%
0.03%
-61.8%
Q3 2021$6,886,000909,6660.08%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders